<p>*PTCL includes peripheral T-cell lymphoma not otherwise specified, angioimmunoblastic T-cell lymphoma, anaplastic large cell lymphoma, and NK/T cell lymphoma. Abbreviations: CR1, complete remission after frontline chemotherapy; CI, confidence interval; DLBCL, diffuse large B-cell lymphoma; PTCL, peripheral T-cell lymphoma; LDH, lactate dehydrogenase; IPI, International Prognostic Index; UNL, upper normal limit; CR, complete remission; PR, partial remission; HDT/ASCR, high-dose therapy with autologous stem cell rescue.</p
Peripheral T-cell lymphoma (PTCL) encompasses a heterogeneous group of neoplasms with generally poor...
BACKGROUND: The treatment of children with T-cell lymphoblastic lymphoma (T-LBL) and precursor B-cel...
Abstract BACKGROUND: Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of aggressive lymp...
<p>(A) Overall survival in 171 patients who relapsed after achieving complete remission with frontli...
<p>Post-relapse survival according to (A) relapse detection method and (B) surveillance CT interval ...
Peripheral T-cell lymphoma (PTCL) is a rare, heterogeneous malignancy. Of the 619 patients with rela...
<div><p>We performed a retrospective analysis to identify risk factors and survival outcome for cent...
We performed a retrospective analysis to identify risk factors and survival outcome for central nerv...
<p>A: Cumulative incidence of CNS relapse in patients with PTCL. B: Cumulative incidence of CNS rela...
BACKGROUND:The goal of this study was to perform a systematic review to examine the efficacy and saf...
Full list of author information is available at the end of the articleDiffuse large B-cell lymphoma ...
The goal of this study was to perform a systematic review to examine the efficacy and safety of vari...
Single agents have demonstrated activity in relapsed and refractory (R/R) peripheral T-cell lymphoma...
Purpose To analyze the outcome, including nonrelapse mortality (NRM), relapse rate (RR), progression...
<p>Summary of characteristics of selected studies for primary and secondary outcomes in patients wit...
Peripheral T-cell lymphoma (PTCL) encompasses a heterogeneous group of neoplasms with generally poor...
BACKGROUND: The treatment of children with T-cell lymphoblastic lymphoma (T-LBL) and precursor B-cel...
Abstract BACKGROUND: Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of aggressive lymp...
<p>(A) Overall survival in 171 patients who relapsed after achieving complete remission with frontli...
<p>Post-relapse survival according to (A) relapse detection method and (B) surveillance CT interval ...
Peripheral T-cell lymphoma (PTCL) is a rare, heterogeneous malignancy. Of the 619 patients with rela...
<div><p>We performed a retrospective analysis to identify risk factors and survival outcome for cent...
We performed a retrospective analysis to identify risk factors and survival outcome for central nerv...
<p>A: Cumulative incidence of CNS relapse in patients with PTCL. B: Cumulative incidence of CNS rela...
BACKGROUND:The goal of this study was to perform a systematic review to examine the efficacy and saf...
Full list of author information is available at the end of the articleDiffuse large B-cell lymphoma ...
The goal of this study was to perform a systematic review to examine the efficacy and safety of vari...
Single agents have demonstrated activity in relapsed and refractory (R/R) peripheral T-cell lymphoma...
Purpose To analyze the outcome, including nonrelapse mortality (NRM), relapse rate (RR), progression...
<p>Summary of characteristics of selected studies for primary and secondary outcomes in patients wit...
Peripheral T-cell lymphoma (PTCL) encompasses a heterogeneous group of neoplasms with generally poor...
BACKGROUND: The treatment of children with T-cell lymphoblastic lymphoma (T-LBL) and precursor B-cel...
Abstract BACKGROUND: Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of aggressive lymp...